This content is machine translated Amyotrophic lateral sclerosis (ALS) Risk factor heavy physical work Researchers at Ulm University Medical Center have identified heavy physical labor as a risk factor for the incurable nerve disease amyotrophic lateral sclerosis (ALS). In their technical publication, which is…
View Post 3 min This content is machine translated Tetanus toxin The first active ingredient against muscle loss Stroke, multiple sclerosis or spinal cord injuries are among the most common neurological diseases in which permanent paralysis and muscle atrophy can result from a disorder in the central nervous…
View Post 5 min This content is machine translated Focal spasticities “An enormous relief in daily practice”. Botulinum toxins are increasingly used in the treatment of spasticity, but so far different preparations have been used depending on the etiology and localization [1]. A new preparation can now…
View Post 3 min This content is machine translated Multiple sclerosis Personalized medicine at the cutting edge Intensive research in the field of multiple sclerosis (MS) has led to the availability of different treatment options – depending on the form of the disease and its severity. This…
View Post 14 min This content is machine translated Epilepsy Patient-centered pharmacotherapy of epilepsy. The arsenal of available pharmacotherapies for the treatment of epilepsy has expanded dramatically in recent years. More targeted selection and prioritization based on the form of epilepsy, consideration of comorbidities,… CME-Test
View Post 3 min This content is machine translated Neurodegenerative disease Football better with head protection in the future? A study from Scotland shows that professional football players have a 3.5 times higher risk of developing a neurodegenerative disease later in life compared to the general population. Players in…
View Post 3 min This content is machine translated Spinal muscular atrophy in infants (SMA type 1) European study confirms effectiveness Spinal muscular atrophy type 1 (SMA1) is a congenital neurological disorder with severe muscle weakness and wasting (muscle atrophy). Untreated, affected children barely reach the age of three. However, treatment…
View Post 2 min This content is machine translated Neuroimmunology Podcasts provide insight into rare diseases Rare diseases have one thing in common: only a few people are really familiar with the symptoms and possible treatment options. Three different podcasts now take you into the exciting…
View Post 2 min This content is machine translated Spinal muscular atrophy Single-agent gene therapy shows transformative therapeutic benefit New trial data demonstrate age-appropriate development and achievement of motor milestones in presymptomatic children with SMA using single-agent gene therapy, without any respiratory or nutritional support or serious treatment-related adverse…
View Post 3 min This content is machine translated Multiple sclerosis Future prospects: focus on personalized therapy Approximately 15,000 people in Switzerland are diagnosed with multiple sclerosis. The disease is not yet curable. Still. This is because ever better knowledge of the pathophysiology of the disease is…
View Post 4 min This content is machine translated "Mild Cognitive Impairment" (MCI). Ginkgo biloba for the improvement of neurocognitive symptoms Patients with mild cognitive function impairment – mostly affecting those over 60 years of age – may benefit from symptomatic therapy based on a standardized extract of ginkgo. This is…
